Privacy Note
This sample uses public or synthetic strategy data. It does not require source code, private signals, exchange API keys, or live account access.
The purpose of the report is to demonstrate how StratVitals reviews risk structure, not to reveal or copy proprietary strategy logic.
Executive Summary
Profit is an outcome, not a diagnosis.
No source code required.
This is not investment advice.
This is a fictional demo for product demonstration only.
Submitted Strategy Profile
Strategy Name
Demo Breakout Strategy
Backtest or Trading Period
2024-01-01 to 2025-12-31
Fee Setting
0.04% per side
Data Completeness Check
Data coverage Partial gaps detected around volatile sessions.
Sample size Usable for an initial review, but not enough for final production confidence.
Fee impact Fee drag may materially reduce reported profit after execution costs.
Drawdown behavior Peak-to-trough pressure requires manual review before live-readiness decisions.
Strategy Health Quick Score
The demo strategy receives 61 / 100, which indicates the strategy may be worth deeper review but should not be treated as live-ready from profit alone.
Suggested Next Step: Focused Strategy Health Diagnosis
Risk Flags
Drawdown RiskFee Impact RiskMissing Data Risk
These flags are preliminary and based on behavior evidence from the submitted report, not hidden rules or proprietary source code.
Preliminary Diagnosis
The reported PnL is positive in this synthetic sample, but drawdown pressure, fee drag, and possible missing data reduce confidence in strategy readiness.
The next diagnosis should inspect risk structure, PnL traceability, trade distribution, worst-loss clusters, fee-adjusted results, and whether the breakout entries degrade during sideways periods.
Recommended Next Steps
Move from a Standard Strategy Health Quick Check to a Focused Strategy Health Diagnosis before allocating real capital.
The focused review can examine MAE / MFE, Signal Log quality, execution assumptions, sample gaps, and live-readiness risk.
Privacy Note
The first-layer quick report does not require source code, private signals, exchange API keys, or live account access. StratVitals can review exported backtest summaries, trade logs, signal logs, risk metrics, and anonymized evidence while keeping proprietary strategy logic private.
Disclaimer
StratVitals is designed for historical data research, strategy risk diagnosis, backtest quality review, and educational analysis. It does not provide investment advice, financial advice, trading signals, copy trading, account management, or profit guarantees.
This sample report uses fictional demo data for product demonstration only.